A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased
Completed
Sanofi
Phase 3
2001-11-01
This is a multicentre, randomized, double-blind, placebo controlled study. During this study
all the patients will receive background venous thromboembolism (VTE) mechanical prophylaxis
with intermittent pneumatic compression (IPC).
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased
Completed
GlaxoSmithKline
Phase 3
2001-11-01
This is a multicentre, randomized, double-blind, placebo controlled study. During this study
all the patients will receive background venous thromboembolism (VTE) mechanical prophylaxis
with intermittent pneumatic compression (IPC).
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
Withdrawn
Schering-Plough
Phase 2
2003-04-01
The purpose of this research study is to obtain experience in the use of fondaparinux
(Arixtra) as compared to heparin when administered to patients who undergo percutaneous
coronary intervention (PCI). PCI is a mechanical procedure used to widen the narrowing in a
coronary artery in patients with symptomatic coronary artery disease. Fondaparinux and
heparin are drugs that inhibit blood clotting.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
